RxDoctor Payments Data

Beverly Clark, APRN

Family · Moore, OKNPI 1417624362

Payments from drug & device makers

$464in general payments, 2019–2025

Across 20 payments — averaging $23.19 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • GSK$114
  • UCB, Inc.$75
  • AstraZeneca$69
  • Argenx US, Inc.$31
  • Lundbeck LLC$22
  • Biogen$21
  • plus $131 from 8 others

What the payments were for

  • Food & beverage$464100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$464 in reported general payments places this provider in the 55th percentile of 2,026 family providers in Oklahoma.

See all family providers in Oklahoma

Medicare billing

Part B allowed, 2024
$30,859
Medicare patients
129
Services billed
482

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide17$29,597
JardianceEmpagliflozin22$21,913
FarxigaDapagliflozin Propanediol13$21,294
EliquisApixaban14$12,484
Lantus SolostarInsulin Glargine,hum.Rec.Anlog12$2,589
Atorvastatin Calcium91$1,167
Levothyroxine Sodium73$884
Gabapentin34$789
Fluticasone Propionate28$588
Bupropion XlBupropion Hcl22$582
Rosuvastatin Calcium41$504
Duloxetine Hcl23$496
Albuterol Sulfate HfaAlbuterol Sulfate28$468
Omeprazole35$435
Amlodipine Besylate31$261

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$14$29,59717 claims
AstraZenecaFarxiga$69$21,29413 claims
PfizerEliquis$17$12,48414 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 55th percentile of 2,026 family providers in Oklahoma.

Other family in Moore

See the full list for Oklahoma

Where these figures come from

Is this you, or does something look wrong? →